(VIANEWS) - Robert Half International (RHI), Neurocrine Biosciences (NBIX), Repligen Corporation (RGEN) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Robert Half International (RHI)
20.3% sales growth and 41.84% return on equity
Robert Half International Inc. offers staffing services and risk consulting in North America and South America.
Robert Half International's sales growth this year is expected to be 25.2% and 9% for next year.
Year-on-year quarterly revenue growth grew by 43.9%, now sitting on 6B for the twelve trailing months.
Volume
Today's last reported volume for Robert Half International is 801463 which is 8.12% below its average volume of 872325.
Robert Half International's sales growth for the next quarter is 20.3%. The company's growth estimates for the present quarter and the next is 72.6% and 34.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 41.84%.
Volatility
Robert Half International's last day, last week, and last month's current intraday variation average was 0.36%, 3.53%, and 1.81%, respectively.
Robert Half International's highest amplitude of average volatility was 3.61% (day), 5.63% (last week), and 3.25% (last month), respectively.
Robert Half International's Stock Yearly Top and Bottom Value
Robert Half International's stock is valued at $97.96 at 20:22 EST, way below its 52-week high of $125.77 and way higher than its 52-week low of $83.46.
Robert Half International's Moving Average
Robert Half International's value is way below its 50-day moving average of $113.82 and way under its 200-day moving average of $109.35.2. Neurocrine Biosciences (NBIX)
18.7% sales growth and 7.17% return on equity
Neurocrine Biosciences, Inc. is a neuropharmaceutical company that focuses on neuroscience. It develops, delivers, and tests treatments for neurological, endocrine, or psychiatric conditions.
Neurocrine Biosciences's sales growth this year is anticipated to be 20.4% and 16.9% for next year.
Year-on-year quarterly revenue growth grew by 25.9%, now sitting on 1.13B for the twelve trailing months.
Volume
Today's last reported volume for Neurocrine Biosciences is 1080180 which is 44.11% above its average volume of 749535.
Neurocrine Biosciences's sales growth for the next quarter is 18.7%. The company's growth estimates for the present quarter and the next is 32.6% and 160.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.17%.
Volatility
Neurocrine Biosciences's last day, last week, and last month's current intraday variation average was 7.20%, 3.07%, and 1.55%, respectively.
Neurocrine Biosciences's highest amplitude of average volatility was 7.34% (day), 5.92% (last week), and 3.32% (last month), respectively.
Neurocrine Biosciences's Stock Yearly Top and Bottom Value
Neurocrine Biosciences's stock is valued at $79.55 at 20:22 EST, way under its 52-week high of $108.02 and way above its 52-week low of $71.88.
Neurocrine Biosciences's Moving Average
Neurocrine Biosciences's value is way below its 50-day moving average of $92.86 and way under its 200-day moving average of $90.46.3. Repligen Corporation (RGEN)
16.7% sales growth and 8.78% return on equity
Repligen Corporation designs and markets bioprocessing technology and systems that can be used in the biological drug manufacturing process. This includes North America, Europe and Asia Pacific.
Repligen Corporation's sales growth this year is expected to be 17.3% and 13.4% for next year.
Year-on-year quarterly revenue growth grew by 44.5%, now sitting on 734.1M for the twelve trailing months.
Volume
Today's last reported volume for Repligen Corporation is 665053 which is 26.24% above its average volume of 526796.
Repligen Corporation's sales growth for the next quarter is 16.7%. The company's growth estimates for the present quarter and the next is a negative 8.9% and negative -9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.78%.
Volatility
Repligen Corporation's last day, last week, and last month's current intraday variation average was 0.98%, 2.67%, and 3.24%, respectively.
Repligen Corporation's highest amplitude of average volatility was 5.41% (day), 5.64% (last week), and 5.88% (last month), respectively.
Repligen Corporation's Stock Yearly Top and Bottom Value
Repligen Corporation's stock is valued at $156.97 at 20:22 EST, way under its 52-week high of $327.32 and way above its 52-week low of $138.41.
Repligen Corporation's Moving Average
Repligen Corporation's worth is below its 50-day moving average of $171.34 and way below its 200-day moving average of $232.27.4. Avery Dennison Corporation (AVY)
10.8% sales growth and 47.79% return on equity
Avery Dennison Corporation sells and produces pressure sensitive materials around the world.
Avery Dennison Corporation's sales growth this year is anticipated to be 19.9% and 7% for next year.
Year-on-year quarterly revenue growth grew by 9.7%, now sitting on 8.22B for the twelve trailing months.
Volume
Today's last reported volume for Avery Dennison Corporation is 486120 which is 27.55% below its average volume of 671047.
Avery Dennison Corporation's sales growth for the next quarter is 10.8%. The company's growth estimates for the current quarter and the next is a negative 6.2% and 0.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 47.79%.
Volatility
Avery Dennison Corporation's last day, last week, and last month's current intraday variation average was 0.39%, 2.08%, and 1.79%, respectively.
Avery Dennison Corporation's highest amplitude of average volatility was 2.47% (day), 2.86% (last week), and 3.23% (last month), respectively.
Avery Dennison Corporation's Stock Yearly Top and Bottom Value
Avery Dennison Corporation's stock is valued at $167.85 at 20:22 EST, way below its 52-week high of $229.24 and above its 52-week low of $156.51.
Avery Dennison Corporation's Moving Average
Avery Dennison Corporation's worth is below its 50-day moving average of $172.21 and way below its 200-day moving average of $200.31.5. Extra Space Storage (EXR)
10.2% sales growth and 22.41% return on equity
Extra Space Storage Inc. is a self-managed and managed REIT with headquarters in Salt Lake City. It also belongs to the S&P 500.
Extra Space Storage's sales growth this year is anticipated to be 11.7% and 6.1% for next year.
Year-on-year quarterly revenue growth grew by 18.3%, now sitting on 1.47B for the twelve trailing months.
Volume
Today's last reported volume for Extra Space Storage is 546046 which is 28.12% below its average volume of 759672.
Extra Space Storage's sales growth is a negative 0% for the current quarter and 10.2% for the next. The company's growth estimates for the present quarter and the next is 37.5% and 1.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 22.41%.
Volatility
Extra Space Storage's last day, last week, and last month's current intraday variation average was 4.49%, 3.61%, and 1.30%, respectively.
Extra Space Storage's highest amplitude of average volatility was 4.88% (day), 4.34% (last week), and 2.82% (last month), respectively.
Extra Space Storage's Stock Yearly Top and Bottom Value
Extra Space Storage's stock is valued at $169.67 at 20:22 EST, way under its 52-week high of $211.20 and way above its 52-week low of $106.56.
Extra Space Storage's Moving Average
Extra Space Storage's value is way under its 50-day moving average of $193.21 and higher than its 200-day moving average of $167.91.6. Huttig Building Products (HBP)
9.5% sales growth and 71.99% return on equity
Huttig Building Products, Inc., along with its affiliates, distributes building materials, millwork, and wood products to new residential construction, renovation, remodel, and repair in the United States.
Huttig Building Products's sales growth this year is expected to be 11.5% and 5.3% for next year.
Year-on-year quarterly revenue growth grew by 24.8%, now sitting on 937.8M for the twelve trailing months.
Volume
Today's last reported volume for Huttig Building Products is 304279 which is 17.95% below its average volume of 370873.
Huttig Building Products's sales growth is a negative 0% for the ongoing quarter and 9.5% for the next. The company's growth estimates for the present quarter and the next is a negative 0% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 71.99%.
Huttig Building Products's Stock Yearly Top and Bottom Value
Huttig Building Products's stock is valued at $10.70 at 20:22 EST, below its 52-week high of $11.35 and way higher than its 52-week low of $4.78.
Huttig Building Products's Moving Average
Huttig Building Products's worth is higher than its 50-day moving average of $10.14 and way higher than its 200-day moving average of $8.35.7. Align Technology (ALGN)
9.1% sales growth and 22.52% return on equity
Align Technology, Inc., a medical technology company, develops, produces, and markets Invisalign clear aligners, iTero intraoral scans, as well as services for general practitioners dentists, orthodontists, and other dental professionals.
Align Technology's sales growth this year is expected to be 8.5% and 18.7% for next year.
Year-on-year quarterly revenue growth grew by 23.6%, now sitting on 3.95B for the twelve trailing months.
Volume
Today's last reported volume for Align Technology is 614928 which is 36.98% below its average volume of 975881.
Align Technology's sales growth is a negative 0% for the ongoing quarter and 9.1% for the next. The company's growth estimates for the present quarter and the next is a negative 24.3% and negative -9.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 22.52%.
Volatility
Align Technology's last day, last week, and last month's current intraday variation average was 1.78%, 3.00%, and 4.40%, respectively.
Align Technology's highest amplitude of average volatility was 5.01% (day), 4.31% (last week), and 6.40% (last month), respectively.
Align Technology's Stock Yearly Top and Bottom Value
Align Technology's stock is valued at $273.70 at 20:22 EST, way below its 52-week high of $737.45 and higher than its 52-week low of $250.64.